Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter sent Tue, 11/08/2022 - 13:18 Newsletter Test sent to:sly@lundbeck.com Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://brazil.progress.im/pt-br Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter sent Tue, 11/08/2022 - 13:18 Newsletter Test sent to:sly@lundbeck.com Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://brazil.progress.im/pt-br Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 Anonymous